関連する実験動画
Updated: Aug 7, 2026

13:26
Induction and Monitoring of Active Delayed Type Hypersensitivity (DTH) in Rats
Published on: July 19, 2007
まとめ
ワルファリンによる全身性抗凝固薬は,皮膚検査の反応と組織因子生成を減少させました. しかし,リンパ球の変容は影響を受けず,凝固が皮膚検査の反応の鍵であることを示唆しました.
科学分野:
- 免疫学 免疫学とは
- 血液学 ヘマトロジ
- 皮膚科 皮膚科について
背景:
- 皮膚検査の反応性は,遅延過敏性の測定値である.
- 免疫反応における凝固系の役割は完全に理解されていません.
- 組織因子は,凝固カスケードの主要なイニシアターです.
研究 の 目的:
- 皮膚検査の反応性に対する全身性抗凝固薬の影響を調査する.
- リンパ球変容に対する抗凝固剤の効果を決定する.
- 単核細胞組織因子生成に対する抗凝固剤の影響を評価する.
主な方法:
- 24人の健康なボランティアは,ワルファリンによる全身の抗凝固薬を投与された.
- 抗凝固薬の投与前と投与中に皮膚検査を行った.
- リンパ球変換アッセイと単核細胞組織因子生成アッセイを実施した.
主要な成果:
- ワルファリン治療は,皮膚検査の耐久性を著しく減少させた.
- 単核細胞組織因子の生成は,抗凝固剤によって減少した.
- リンパ球の変容は,抗凝固療法中に変化しませんでした.
結論:
- 凝固メカニズム,特に組織因子生成は,ヒトの皮膚テスト硬化症の発生に重要な役割を果たします.
- 抗凝固薬はリンパ球の変容を阻害しない.
- これらの発見は,血静と細胞の免疫反応の相互作用を強調しています.
関連する概念動画
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...

